Source: Indian Pharma Post

Aleor: Aleor Dermaceuticals receives USFDA approval for Docosanol Cream

Docosanol Cream, 10% (OTC) has an estimated market size of US$60 million for twelve months ending December 2021 according to IQVIA

Read full article »

Aleor's Competitors | Aleor's News | Aleor's Financials

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

250-500

Chairman

R. K. Baheti

CEO Approval Rating

90/100

Aleor is an India-based medical research company that develops and manufactures dermatology products such as cream, gel, ointment, shampoo and lotion across the globe.